Loading viewer...
earnings
Format: PDF earnings
TGS presents Q2 2024 earnings results with total POC revenues of USD 215 million and strong contract inflow of USD 368 million. The presentation covers operational highlights including early sales performance, proprietary revenues, and the completion of the PGS transaction on July 1, 2024.
investor_presentation
15 Pages
earnings
38 Pages
Brink's Company
Alexion Pharmaceuticals Q2 2016 Earnings Call
earningsearnings
37 Pages
Alexion Pharmaceuticals